A Risk Sciences International news item posted on May 25, 2021 and last updated on May 25, 2021

The Center for Alternatives to Animal Testing and the Animal-Free Safety Assessment recently held their annual meeting on advancing toxicity testing in the 21st century (TT21C). This informal event provided brief updates on cutting edge approaches in toxicology that have accrued since the publication of the 2007 U.S. National Research Council report on Toxicity Testing in the 21st Century: A Vision and a Strategy.

The meeting is part of an annual series of events that, to date, have been held as satellite meetings of the Society of Toxicology (SOT) conventions. This year, however, with the SOT convention held virtually, it was decided to hold the TT21C meeting virtually as well.

Martin Stephens (Johns Hopkins University), who served on the NRC committee along with Daniel Krewski, welcomed the attendees, followed by brief informal updates as follows:
• ToxCast – Maureen Gwinn (EPA)
• Tox21 – Anton Simeonov (NCATS)
• Organ-on-a-chip & Predictive Toxicology Roadmap – Suzanne Fitzpatrick (FDA)
• Progress in implementing NAMs under TSCA – Louis (Gino) Scarano (EPA)
• ICCVAM/NICEATM – Nicole Kleinstreuer (NICEATM)
• EU-ToxRisk – Bob van de Water (Leiden University)
• AI, iPSC and MPS Projects for Systemic Toxicity – Hajime Kojima (JaCVAM)
• CAAT Activities – Thomas Hartung (Johns Hopkins)
• Evidence-Based Toxicology Collaboration – Katya Tsaioun (Johns Hopkins)
• Animal-Free Safety Assessment Collaboration – Kate Willett (HSI)
• Commentary – Daniel Krewski (U. Ottawa/RSI)

The full meeting (2h34) is available on YouTube and embedded here.

Updates on Activities Related to 21st Century Toxicology (Webinar)

More RSI News

IAI climate change report

April 12, 2022

The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and…

Quinolones and risk of acute liver failure

April 12, 2022

Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…

RSI launches Global Risk Census

March 1, 2022

Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be…

US FDA FAERS and quinolones

June 22, 2021

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised…